CPIX vs. ETON
CPIX (Cumberland Pharmaceuticals Inc.) and ETON (Eton Pharmaceuticals Inc) are both stocks. Both operate in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Over the past 5 years, CPIX returned 15.50%/yr vs 55.29%/yr for ETON. Their 0.08 correlation means their historical movements had little consistent relationship.
Performance
CPIX vs. ETON - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CPIX achieves a 67.84% return, which is significantly lower than ETON's 174.51% return.
CPIX
- 1D
- -0.74%
- 1M
- 4.87%
- 6M
- 78.13%
- YTD
- 67.84%
- 1Y
- 89.77%
- 3Y*
- 66.39%
- 5Y*
- 15.50%
- 10Y*
- 3.85%
- ALL TIME*
- -5.36%
ETON
- 1D
- -5.32%
- 1M
- 23.79%
- 6M
- 209.26%
- YTD
- 174.51%
- 1Y
- 228.52%
- 3Y*
- 154.38%
- 5Y*
- 55.29%
- 10Y*
- —
- ALL TIME*
- 29.32%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $942.95K | $842.80K | $677.16K | |
| $26.85M | $22.65M | $16.80M |
CPIX vs. ETON - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
CPIX Cumberland Pharmaceuticals Inc. | 67.84% | 67.93% | 32.28% | -20.37% | -51.82% | 58.31% | -42.72% | -14.59% | -7.23% |
ETON Eton Pharmaceuticals Inc | 174.51% | 26.95% | 204.11% | 55.32% | -34.27% | -47.23% | 12.92% | 17.65% | -4.23% |
Correlation
The correlation between CPIX and ETON is 0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.07 |
Correlation (3Y) Balances recent behavior with more history. | 0.05 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.08 |
Correlation (All Time) Calculated using the full available price history since Nov 13, 2018 | 0.08 |
Fundamentals
CPIX:
$100.09M
ETON:
$1.27B
CPIX:
-$0.49
ETON:
-$0.05
CPIX:
2.38
ETON:
15.19
CPIX:
4.62
ETON:
47.83
CPIX:
$41.94M
ETON:
$86.93M
CPIX:
$34.76M
ETON:
$47.61M
CPIX:
-$3.18M
ETON:
$5.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CPIX vs. ETON — Risk / Return Rank
CPIX
ETON
CPIX vs. ETON - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cumberland Pharmaceuticals Inc. (CPIX) and Eton Pharmaceuticals Inc (ETON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CPIX | ETON | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.05 | ||
| Sortino ratioReturn per unit of downside risk | -2.28 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.55 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | 1.79 | 6.34 | -4.55 |
| Martin ratioReturn relative to average drawdown | 3.71 | 13.13 | -9.42 |
Loading charts...
Drawdowns
CPIX vs. ETON - Drawdown Comparison
The maximum CPIX drawdown since its inception was -93.78%, which is greater than ETON's maximum drawdown of -79.94%. Use the drawdown chart below to compare losses from any high point for CPIX and ETON.
Loading charts...
Drawdown Indicators
| CPIX | ETON | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.78% | -79.94% | -13.84% |
Max Drawdown (1Y)Largest decline over 1 year | -52.62% | -36.17% | -16.45% |
Max Drawdown (3Y)Largest decline over 3 years | -71.94% | -45.65% | -26.29% |
Max Drawdown (5Y)Largest decline over 5 years | -84.73% | -69.35% | -15.38% |
Max Drawdown (10Y)Largest decline over 10 years | -86.68% | — | — |
Current DrawdownCurrent decline from peak | -60.81% | -5.32% | -55.49% |
Average DrawdownAverage peak-to-trough decline | -70.69% | -36.98% | -33.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.34% | 17.44% | +7.90% |
Volatility
CPIX vs. ETON - Volatility Comparison
Cumberland Pharmaceuticals Inc. (CPIX) has a higher volatility of 29.50% compared to Eton Pharmaceuticals Inc (ETON) at 20.28%. This indicates that CPIX's price experiences larger fluctuations and is considered to be riskier than ETON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CPIX | ETON | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.50% | 20.28% | +9.22% |
Volatility (6M)Calculated over the trailing 6-month period | 60.76% | 43.44% | +17.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 88.18% | 55.80% | +32.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 115.14% | 63.59% | +51.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 87.01% | 63.81% | +23.20% |
Dividends
CPIX vs. ETON - Dividend Comparison
Neither CPIX nor ETON has paid dividends to shareholders.
Financials
CPIX vs. ETON - Financials Comparison
This section allows you to compare key financial metrics between Cumberland Pharmaceuticals Inc. and Eton Pharmaceuticals Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CPIX vs. ETON - Profitability Comparison
CPIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Cumberland Pharmaceuticals Inc. reported a gross profit of 7.20M and revenue of 9.13M. Therefore, the gross margin over that period was 78.8%.
ETON - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Eton Pharmaceuticals Inc reported a gross profit of 14.74M and revenue of 24.27M. Therefore, the gross margin over that period was 60.7%.
CPIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Cumberland Pharmaceuticals Inc. reported an operating income of -3.13M and revenue of 9.13M, resulting in an operating margin of -34.3%.
ETON - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Eton Pharmaceuticals Inc reported an operating income of 2.41M and revenue of 24.27M, resulting in an operating margin of 10.0%.
CPIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Cumberland Pharmaceuticals Inc. reported a net income of -3.29M and revenue of 9.13M, resulting in a net margin of -36.0%.
ETON - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Eton Pharmaceuticals Inc reported a net income of 1.55M and revenue of 24.27M, resulting in a net margin of 6.4%.
Frequently Asked Questions
CPIX and ETON have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CPIX has higher volatility (29.50%) compared to ETON (20.28%). In terms of maximum drawdown, CPIX dropped -93.78% vs ETON's -79.94%.
ETON currently has the higher Sharpe Ratio (4.12 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CPIX and ETON
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer